Journal Mobile Options
Table of Contents
Vol. 31, No. 4, 2008
Issue release date: November 2008
Section title: Original Paper
Free Access
Neuroepidemiology 2008;31:229–240
(DOI:10.1159/000163097)

Surgery and Risk of Sporadic Creutzfeldt-Jakob Disease in Denmark and Sweden: Registry-Based Case-Control Studies

Mahillo-Fernandez I.a · de Pedro-Cuesta J.a · Bleda M.J.a · Cruz M.b · Mølbak K.c · Laursen H.d · Falkenhorst G.c · Martínez-Martín P.a · Siden Å.b
aDepartment of Applied Epidemiology, National Center for Epidemiology, and Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Carlos III Institute of Health, Madrid, Spain; bDepartment of Clinical Neurosciences, Neurology Division, Karolinska Institutet, Stockholm, Sweden; cDepartment of Epidemiology, Statens Serum Institute, and dNeuropathology Laboratory, Rigshospitalet, Copenhagen, Denmark
email Corresponding Author

Jesús de Pedro Cuesta

Centro Nacional de Epidemiología, Instituto de Salud Carlos III

Calle Sinesio Delgado 6, Pabellón 12

ES–28029 Madrid (Spain)

Tel. +34 91 8222 650, Fax +34 91 3877 815, E-Mail jpedro@isciii.es


References

  1. Prusiner SB: The prion diseases. Brain Pathol 1998;8:499–513.
  2. Weissmann C, Enari M, Klohn PC, Rossi D, Flechsig E: Transmission of prions. Proc Natl Acad Sci USA 2002;99(suppl 4):16378–16383.
  3. Kondo K, Kuroiwa Y: A case-control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol 1982;11:377–381.
  4. Davanipour Z, Alter M, Sobel E, Asher DM, Gajdusek DC: Creutzfeldt-Jakob disease: possible medical risk factors. Neurology 1985;35:1483–1486.
  5. Harries-Jones R, Knight RSG, Will RG, Cousens SN, Smith PG, Matthews WB: Creutzfeldt-Jakob disease in England and Wales, 1980–1984: a case-control study of potential risk factors. J Neurol Neurosurg Psychiatry 1988;51:1113–1119.
  6. van Duijn CM, Delasnerie-Lauprêtre N, Masullo C, Zerr I, de Silva R, Wientjens DPWM, Brandel JP, Weber T, Bonavita V, Zeidler M, Alpérovitch A, Poser S, Granieri E, Hofman A, Will RG: Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993–95. Lancet 1998;351:1081–1085.
  7. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL: Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 1999;353:69.
  8. Zerr I, Brandel J-P, Masullo C, Wientjens DPWM, de Silva R, Zeidler M, Granieri E, Sampaolo S, van Duijn CM, Delasnerie-Lauprêtre N, Will RG, Poser S: European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol 2000;53:747–754.
  9. Ward HJT, Everington D, Croes EA, Alpérovitch A, Delasnerie-Lauprêtre N, Zerr I, Poser S, van Duijn CM: Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology 2002;59:543–548.
  10. Ward HJ, Everington D, Cousens SN, Smith-Bathgate B, Gillies M, Murray K, Knight RS, Smith PG, Will RG: Risk factors for sporadic Creutzfeldt-Jakob disease. Ann Neurol 2008;63:347–354.
  11. Wientjens DPWM, Davanipour Z, Hofman A, Kondo K, Matthews WB, Will RG, van Duijn CM: Risk factors for Creutzfeldt-Jakob disease: a reanalysis of case-control studies. Neurology 1996;46:1287–1291.
  12. Llewelyn CA, Hewitt PE, Knight RS, Amar K, Cousens S, Mackenzie J, Will RG: Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004;363:417–421.
  13. Peden AH, Head MW, RitchieDL, Bell JE, Ironside JW: Preclinical vCJD after blood transfusion in a codon 129 heterozygous patient. Lancet 2004;364:527–529.
  14. Collinge J: Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry 2005;76:906–919.
  15. Wroe SJ, Pal S, Siddique D, Hyare H, Macfarlane R, Joiner S, Linehan JM, Brandner S, Wadsworth JD, Hewitt P, Collinge J: Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006;368:2061–2067.
  16. Olsen SB, Sheikh A, Peck D, Darzi A: Variant Creutzfeldt-Jakob disease, a cause for concern – Review of the evidence for risk of transmission through abdominal lymphoreticular tissue surgery. Surg Endosc 2005;19:747–750.
  17. Ingrosso L, Pisani F, Pocchiari M: Transmission of the 263K scrapie strain by the dental route. J Gen Virol 1999;80:3043–3047.
  18. Rábano A, de Pedro-Cuesta J, Mølbak K, Siden Å, Calero M, Laursen H: Tissue classification for the epidemiologic assessment of surgical transmission of sporadic Creutzfeldt-Jakob disease. A proposal on hypothetical risk levels. BMC Public Health 2005;5:9.
  19. Gravenor MB, Stallard N, Curnow R, McLean AR: Repeated challenge with prion disease: the risk of infection and impact on incubation period. Proc Natl Acad Sci USA 2003;100:10960–10965.
  20. Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, Bernheimer H, Cardone F, Delasnerie-Lauprêtre N, Cuadrado Corrales N, Ladogana A, Bodemer M, Fletcher A, Awan T, Ruiz Bremón A, Budka H, Laplanche JL, Will RG, Poser S: Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:811–815.
  21. Klassifikation av operationer, 6:e upplagan. Socialstyrelsen. Stockholm, Norstedts, 1993.
  22. Operations og Behandlings-Klassifikation, 3 udgave. Sundhedsstyrelsen. Copenhagen, Munksgaard, 1988.
  23. Nordic Medico-Statistical Committee: NOMESCO Classification of Surgical Procedures. Copenhagen, NOTEX, 2003.
  24. Greenland S: Applications of stratified analysis methods; in Rothman KJ, Greenland S (eds): Modern Epidemiology, ed 2. Philadelphia, Lippincott & Raven, 1998, pp 281–300.
  25. Lundberg PO: Creutzfeldt-Jakob disease in Sweden. J Neurol Neurosurg Psychiatry 1998;65:836–841.
  26. Brown P, Preece MA, Brandel J-P, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, Huillard d’Aignaux J, Cervenáková L, Fradkin J, Schonberger LB, Collins SJ: Iatrogenic Creutzfeldt-Jakob disease at the millenium. Neurology 2000;55:1075–1081.
  27. Salvan A, Stayner L, Steenland K, Smith R: Selecting an exposure lag period. Epidemiology 1995;6:387–390.
  28. Norell SE: Obtaining information on exposures; in Norell SE (eds): Workbook of Epidemiology. Oxford, Oxford University Press, 1995, pp 75–98.
  29. Aguzzi A, Heikenwalder M, Miele G: Progress and problems in the biology, diagnostics, and therapeutics of prion diseases. J Clin Invest 2004;114:153–160.
  30. Stroobant N, Van Nooten G, Van Belleghem Y, Vingerhoets G: Relation between neurocognitive impairment, embolic load, and cerebrovascular reactivity following on- and off-pump coronary artery bypass grafting. Chest 2005;127:1967–1976.
  31. Barash JA, Johnson BT, Gregorio I: Is surgery a risk factor for Creutzfeldt-Jakob disease? Outcome variation by control choice and exposure assessments. Infect Control Hosp Epidemiol 2008;29:212–218.
  32. S-Juan P, Ward HJ, De Silva R, Knight R, Will RG: Ophthalmic surgery and Creutzfeldt-Jakob disease. Br J Ophthalmol 2004;88:446–449.
  33. Hamaguchi T, Noguchi-Shinohara M, Nakamura Y, Sato T, Kitamoto T, Mizusawa H, Yamada M: Ophthalmic surgery in prion diseases. Emerg Infect Dis 2007;13:162–164.
  34. Ward HJ, Everington D, Cousens SN, Smith-Bathgate B, Leitch M, Cooper S, Heath C, Knight RS, Smith PG, Will RG: Risk factors for variant Creutzfeldt-Jakob disease: a case-control study. Ann Neurol 2006;59:111–120.
  35. Linsell L, Cousens SN, Smith PG, Knight RS, Zeidler M, Stewart G, de Silva R, Esmonde TF, Ward HJ, Will RG: A case-control study of sporadic Creutzfeldt-Jakob disease in the United Kingdom. Analysis of clustering. Neurology 2004;63:2077–2083.
  36. D’Aignaux JH, Cousens SN, Delasnerie-Lauprêtre N, Brandel JP, Salomon D, Laplanche JL, Hauw JJ, Alpérovitch A: Analysis of the geographical distribution of sporadic Creutzfeldt-Jakob disease in France between 1992 and 1998. Int J Epidemiol 2002;31:490–495.
  37. Zarranz JJ, Digon A, Atarés B, Rodríguez-Martínez AB, Arce A, Carrera N, Fernández-Manchola I, Fernández-Martínez M, Fernández-Maiztegui C, Forcadas I, Galdos L, Gómez-Esteban JC, Ibáñez A, Lezcano E, López de Munain A, Martí-Massó JF, Mendibe MM, Urtasun M, Uterga JM, Saracibar N, Velasco F, de Pancorbo MM: Phenotypic variability in familial prion diseases due to the D178N mutation. J Neurol Neurosurg Psychiatry 2005;76:1491–1496.
  38. Glatzel M, Rogivue C, Ghani AC, Streffer JR, Amsler L, Aguzzi A: Incidence of Creutzfeldt-Jakob disease in Switzerland. Lancet 2002;360:139–141.